We previously showed that RHL was highly active in targeting the MEK/extracellular signal-regulated kinase (ERK) signal pathway and induced apoptosis and cell cycle arrest in human ovarian cancer cells (12). The gene discussed is MAP2K7; the disease is ovarian carcinoma.